U.S. flag

An official website of the United States government

NM_000256.3(MYBPC3):c.3392T>C (p.Ile1131Thr) AND Cardiovascular phenotype

Germline classification:
Likely benign (1 submission)
Last evaluated:
Jan 2, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000244315.11

Allele description [Variation Report for NM_000256.3(MYBPC3):c.3392T>C (p.Ile1131Thr)]

NM_000256.3(MYBPC3):c.3392T>C (p.Ile1131Thr)

Gene:
MYBPC3:myosin binding protein C3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p11.2
Genomic location:
Preferred name:
NM_000256.3(MYBPC3):c.3392T>C (p.Ile1131Thr)
HGVS:
  • NC_000011.10:g.47332912A>G
  • NG_007667.1:g.24791T>C
  • NM_000256.3:c.3392T>CMANE SELECT
  • NP_000247.2:p.Ile1131Thr
  • LRG_386t1:c.3392T>C
  • LRG_386:g.24791T>C
  • LRG_386p1:p.Ile1131Thr
  • NC_000011.9:g.47354463A>G
  • Q14896:p.Ile1131Thr
  • c.3392T>C
Protein change:
I1131T
Links:
UniProtKB: Q14896#VAR_029428; dbSNP: rs370890951
NCBI 1000 Genomes Browser:
rs370890951
Molecular consequence:
  • NM_000256.3:c.3392T>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000319934Ambry Genetics
criteria provided, single submitter

(Ambry General Variant Classification Scheme_2022)
Likely benign
(Jan 2, 2019)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Citations

PubMed

The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands.

Alders M, Jongbloed R, Deelen W, van den Wijngaard A, Doevendans P, Ten Cate F, Regitz-Zagrosek V, Vosberg HP, van Langen I, Wilde A, Dooijes D, Mannens M.

Eur Heart J. 2003 Oct;24(20):1848-53.

PubMed [citation]
PMID:
14563344

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.

Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, Ackerman MJ.

J Am Coll Cardiol. 2004 Nov 2;44(9):1903-10.

PubMed [citation]
PMID:
15519027
See all PubMed Citations (8)

Details of each submission

From Ambry Genetics, SCV000319934.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (8)

Description

This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

Last Updated: Apr 20, 2024